|
1
|
Klassen TP: Recent advances in the
treatment of bronchiolitis and laryngitis. Pediatr Clin North Am.
44:249–261. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kabra SK and Ghai OP: Respiratory
disorders. In: Ghai Essentials Pediatrics. 6th edition. CBS
Publishers and Distributors; New Delhi: pp. 352–354. 2004
|
|
3
|
Hall CB, Weinberg GA, Iwane MK, Blumkin
AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA,
Erdman D, et al: The burden of respiratory syncytial virus
infection in young children. N Engl J Med. 360:588–598. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dennis MM: Bonchiolitis. Arch Dis Child
Educ Pract. 90:81–86. 2005.
|
|
5
|
Mathew JL: Hypertonic saline nebulization
for bronchiolitis. Indian Pediatr. 45:987–989. 2008.PubMed/NCBI
|
|
6
|
Gadomski AM and Scribani MB:
Bronchodilators for bronchiolitis. Cochrane Database Syst Rev.
6:CD0012662014.
|
|
7
|
Skjerven HO, Hunderi JO, Brügmann-Pieper
SK, Brun AC, Engen H, Eskedal L, Haavaldsen M, Kvenshagen B, Lunde
J, Rolfsjord LB, et al: Racemic adrenaline and inhalation
strategies in acute bronchiolitis. N Engl J Med. 368:2286–2293.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farley R, Spurling GK, Eriksson L and Del
Mar CB: Antibiotics for bronchiolitis in children under two years
of age. Cochrane Database Syst Rev. 10:CD0051892014.
|
|
9
|
Hartling L, Fernandes RM, Bialy L, Milne
A, Johnson D, Plint A, Klassen TP and Vandermeer B: Steroids and
bronchodilators for acute bronchiolitis in the first two years of
life: Systematic review and meta-analysis. BMJ. 342:d17142011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fernandes RM and Hartling L:
Glucocorticoids for acute viralbronchiolitis in infants and young
children. JAMA. 311:87–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wabnitz DA and Wormald PJ: A blind,
randomized, controlled study on the effect of buffered 0.9 and 3%
sodium chloride intranasal sprays on ciliary beat frequency.
Laryngoscope. 115:803–805. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wills PJ, Hall RL, Chan W and Cole PJ:
Sodium chloride increases the ciliary transportability of cystic
fibrosis and bronchiectasis sputum on the mucusdepleted bovine
trachea. J Clin Invest. 99:9–13. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sood N, Bennett WD, Zeman K, Brown J, Foy
C, Boucher RC and Knowles MR: Increasing concentration of inhaled
saline with or without amiloride: Effect on mucociliary clearence
in normal subjects. Am J Respir Crit Care Med. 167:158–163. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP,
Hopman W, Hotte S and Gander S: Nebulized hypertonic saline in the
treatment of viral bronchiolitis in infants. J Pediatr.
151:266–270, 270.e1. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sarrell EM, Tal G, Witzling M, Someck E,
Houri S, Cohen HA and Mandelberg A: Nebulized 3% hypertonic saline
solution treatment in ambulatory children with viral bronchiolitis
decreases symptoms. Chest. 122:2015–2020. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Mendoza-Sassi RA, Wainwright C
and Klassen TP: Nebulized hypertonic saline solution for acute
bronchiolitis in infants. Cochrane Database Syst Rev.
4:CD0064582008.
|
|
17
|
Robinson M, Hemming AL, Regnis JA, Wong
AG, Bailey DL, Bautovich GJ, King M and Bye PT: Effect of
increasing doses of hypertonic saline on mucociliary clearance in
patients with cystic fibrosis. Thorax. 52:900–903. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomooka LT, Murphy C and Davidson TM:
Clinical study and literature review of nasal irrigation.
Laryngoscope. 110:1189–1193. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delvaux M, Henket M, Lau L, Kange P,
Bartsch P, Djukanovic R and Louis R: Nebulised salbutamol
administered during sputum induction improves bronchoprotection in
patients with asthma. Thorax. 59:111–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mandelberg A, Tal G, Witzling M, Someck E,
Houri S, Balin A and Priel IE: Nebulized 3% hypertonic saline
solution treatment in hospitalized infants with viral
bronchiolitis. Chest. 123:484–487. 2003. View Article : Google Scholar
|
|
21
|
Tal G, Cesar K, Oron A, Houri S, Ballin A
and Mandelberg A: Hypertonic saline epinephrine treatment in
hospitalized infants with viral bronchiolitis reduces
hospitalization stay: 2 years experience. Isr Med Assoc J.
8:169–173. 2006.PubMed/NCBI
|
|
22
|
Luo Z, Fu Z, Liu E, Xu X, Fu X, Peng D,
Liu Y, Li S, Zeng F and Yang X: Nebulized hypertonic saline
treatment in hospitalized children with moderate to severe viral
bronchiolitis. Clin Microbiol Infect. 17:1829–1833. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X
and Fu Z: Nebulized hypertonic saline/salbutamol solution treatment
in hospitalized children with mild to moderate bronchiolitis.
Pediatr Int. 52:199–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miraglia Del Giudice M, Saitta F, Leonardi
S, Capasso M, Niglio B, Chinellato I, Decimo F, Maiello N, Capristo
C, Perrone L and Peroni D: Effectiveness of nebulized hypertonic
saline and epinephrine in hospitalized infants with bronchiolitis.
Int J Immunopathol Pharmacol. 25:485–491. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu S, Baker C, Lang ME, Schrager SM, Liley
FF, Papa C, Mira V, Balkian A and Mason WH: Nebulized hypertonic
saline for bronchiolitis: A randomized clinical trial. JAMA
Pediatr. 168:657–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Florin TA, Shaw KN, Kittick M, Yakscoe S
and Zorc JJ: Nebulized hypertonic saline for bronchiolitis in the
emergency department: A randomized clinical trial. JAMA Pediatr.
168:664–670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharma BS, Gupta MK and Rafik SP:
Hypertonic (3%) saline vs. 0.93% saline nebulization for acute
viral bronchiolitis: A randomized controlled trial. Indian Pediatr.
50:743–747. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Ding S, Li C, Wang Y, Chen Z and
Wang Z: Effects of N-acetylcysteine treatment in acute respiratory
distress syndrome: A meta-analysis. Exp Ther Med. 14:2863–2868.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta HV, Gupta VV, Kaur G, Baidwan AS,
George PP, Shah JC, Shinde K, Malik R, Chitkara N and Bajaj KV:
Effectiveness of 3% hypertonic saline nebulization in acute
bronchiolitis among Indian children: A quasiexperimental study.
Perspect Clin Res. 7:88–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Silver AH, Esteban-Cruciani N, Azzarone G,
Douglas LC, Lee DS, Liewehr S, Nazif JM, Agalliu I, Villegas S,
Rhim HJ, et al: 3% hypertonic saline versus normal saline in
inpatient bronchiolitis: A randomized controlled trial. Pediatrics.
136:1036–1043. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ojha AR, Mathema S, Sah S and Aryal UR: A
comparative study on use of 3% saline versus 0.9% saline
nebulization in children with bronchiolitis. J Nepal Health Res
Counc. 12:39–43. 2014.PubMed/NCBI
|
|
32
|
Flores P, Mendes AL and Neto AS: A
randomized trial of nebulized 3% hypertonic saline with salbutamol
in the treatment of acute bronchiolitis in hospitalized infants.
Pediatr Pulmonol. 51:418–425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Angoulvant F, Bellêttre X, Milcent K,
Teglas JP, Claudet I, Le Guen CG, de Pontual L, Minodier P, Dubos
F, Brouard J, et al: Effect of nebulized hypertonic saline
treatment in emergency departments on the hospitalization rate for
acute bronchiolitis: A randomized clinical trial. JAMA Pediatr.
171:e1713332017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Al-Ansari K, Sakran M, Davidson BL, El
Sayyed R, Mahjoub H and Ibrahim K: Nebulized 5 or 3% hypertonic or
0.9% saline for treating acute bronchiolitis in infants. J Pediatr.
157:630–634, 634.e1. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Teunissen J, Hochs AH, Vaessen-Verberne A,
Boehmer AL, Smeets CC, Brackel H, van Gent R, Wesseling J,
Logtens-Stevens D, de Moor R, et al: The effect of 3 and 6%
hypertonic saline in viral bronchiolitis: A randomised controlled
trial. Eur Respir J. 44:913–921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pandit S, Dhawana N and Thakur D: Utility
of hypertonic saline in the management of acute bronchiolitis in
infants: A randomised controlled study. Int J Clin Pediatr.
2:24–29. 2013.
|
|
37
|
Everard ML, Hind D, Ugonna K, Freeman J,
Bradburn M, Cooper CL, Cross E, Maguire C, Cantrill H, Alexander J
and McNamara PS: SABRE: A multicentrerandomised control trial of
nebulised hypertonic saline in infants hospitalised with acute
bronchiolitis. Thorax. 69:1105–1112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mahesh Kumar KB, Karunakara BP, Manjunath
MN and Mallikarjuna HB: Aerosolised hypertonic saline in
hospitalized young children with acute bronchiolitis: A randomized
controlled clinical trial. J Pediatr Sci. 5:e1742013.
|
|
39
|
Grewal S, Ali S, McConnell DW, Vandermeer
B and Klassen TP: A randomized trial of nebulized 3% hypertonic
saline with epinephrine in the treatment of acute bronchiolitis in
the emergency department. Arch Pediatr Adolesc Med. 163:1007–1012.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anil AB, Anil M, Saglam AB, Cetin N, Bal A
and Aksu N: High volume normal saline alone is as effective as
nebulized salbutamol-normal saline, epinephrine-normal saline, and
3% saline in mild bronchiolitis. Pediatr Pulmonol. 45:41–47. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Espelt MI; Hospital General de Niños Pedro
de Elizalde, : Efficacy of nebulized hypertonic saline in the
treatment of acute bronchiolitis (Hypertonic). ClinicalTrials.gov
Identifier: NCT01238848. http://www.clinicaltrials.gov/ct2/show/NCT01238848?term=espelt+bronchiolitis&rank=1November
11–2010
|
|
42
|
Köse S, Şehriyaroğlu A, Esen F, Özdemir A,
Kardaş Z, Altuğ U, Karakuş E, Özcan A, Kısaarslan AF, Elmalı F, et
al: Comparing the efficacy of 7, 3 and 0.9% saline in moderate to
severe bronchiolitis in infants. Balkan Med J. 33:193–197. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Coffen SE: Bronchiolitis: Inpatient focus.
Pediatr Clin North Am. 52:1047–1057. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hall CB: Respiratory syncytial virus. In:
Textbook of Pediatric Infectious Diseases. 3rd. Philadelphia;
Saunders: pp. pp1633–1656. 1991
|
|
45
|
Hall CB: Respiratory syncytial virus and
parainfluenza virus. N Engl J Med. 344:1917–1928. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Darville T and Yamauchi T: Respiratory
syncytial virus. Pediatr Rev. 19:55–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Meert KL, Sarnaik AP, Gelmini MJ and
Lieh-Lai MW: Aerosolized ribavirin in mechanically ventilated
children with respiratory syncytial virus lower respiratory tract
disease: A prospective double-blind, randomized trial. Crit Care
Med. 22:566–572. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Moler FW, Steinhart CM, Ohmit SE and
Stidham GL: Effectiveness of ribavirin in otherwise well infants
with respiratory syncytial virus-associated respiratory failure. J
Pediatr. 128:442–448. 1996. View Article : Google Scholar
|
|
49
|
Guerguerian AM, Gauthier M, Lebel MH,
Farrell CA and Lacroix J: Ribavirin in ventilated respiratory
syncytial virus bronchiolitis: A randomized, placebo-controlled
trial. Am J Respir Crit Care Med. 160:829–834. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wheeler JG, Wofford J and Turner RB:
Historical cohort evaluation of ribavirin efficacy in respiratory
syncytial virus infection. Pediatr Infect Dis J. 12:209–213. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
van Woensel JB, Wolfs TF, van Aalderen WM,
Brand PL and Kimpen JL: Randomized double blind placebo controlled
trial of prednisolone in children admitted to hospital with
respiratory syncytial virus bronchiolitis. Thorax. 52:634–637.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cade A, Brownlee KG, Conway SP, Haigh D,
Short A, Brown J, Dassu D, Mason SA, Phillips A, Eglin R, et al:
Randomised placebo controlled trial of nebulised corticosteroids in
acute respiratory syncytial viral bronchiolitis. Arch Dis Child.
82:126–130. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Menon K, Sutcliffe T and Klassen TP: A
randomized trial comparing the efficacy of epinephrine with
salbutamol in the treatment of acute bronchiolitis. J Pediatr.
126:1004–1007. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Barr FE, Patel NR and Newth CJ: The
pharmacologic mechanism by which inhaled epinephrine reduces airway
obstruction in respiratory syncytial virus associated
bronchiolitis. J Pediatr. 136:699–700. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bertrand P, Araníbar H, Castro E and
Sánchez I: Efficacy of nebulized epinephrine vs salbutamol in
hospitalized infants with bronchiolitis. Pediatr Pulmonol.
31:384–288. 2001. View Article : Google Scholar
|
|
56
|
Flores G and Horwitz RI: Efficacy of
2-agonists in bronchiolitis: A reappraisal and meta-analysis.
Pediatrics. 100:233–239. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Patterson JE, Bradley JM and Elborn JS:
Airway clearance in bronchiectasis: A randomized crossover trial of
active cycle of breathing techniques (incorporating postural
drainage and vibration) versus test of incremental respiratory
endurance. Chron Respir Dis. 1:127–130. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Charman J and Reid L: Sputum viscosity in
chronic bronchitis, bronchiectasis, asthma and cystic fibrosis.
Biorheology. 9:185–199. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ipek IO, Yalcin EU, Sezer RG and Bozaykut
A: The efficacy of nebulized salbutamol, hypertonic saline and
salbutamol/hypertonic saline combination in moderate bronchiolitis.
Pulm Pharmacol Ther. 24:633–637. 2011. View Article : Google Scholar : PubMed/NCBI
|
